Choosing a droplet pcr machine: how digital pcr counts molecules instead of comparing to a standard curve, what a digital pcr instrument buys on rare targets and in inhibited samples, and the partitioning and threshold questions that decide the number

Digital polymerase chain reaction divides a reaction into thousands of tiny partitions, amplifies each one and counts how many were positive. That converts a comparative measurement against a standard curve into a count, which is why it is used for rare variants, copy number and any sample where an inhibitor would distort a quantitative cycle threshold. This page covers what it buys and what it costs.

the thousands of independent reactions a count is built from
partitions
the statistics that turn positive partitions into a concentration
Poisson
the NIST reference materials a nucleic acid measurement is traceable to
SRM

Figures in this panel are the method's own mechanism and the reference materials a nucleic acid measurement is traceable to, linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply an instrument price index it has not measured.

What the method actually does

  1. Partitioning turns concentration into a count. The reaction is split into many thousands of droplets or wells, each amplifying independently. Counting positives and applying Poisson statistics gives an absolute concentration with no standard curve and no reference material, which is the whole point.
  2. Rare targets are where it wins clearly. A variant present at a small fraction of a background is hard to distinguish by cycle threshold and straightforward to count when it occupies its own partitions. Rare mutation detection and copy number differences are the established applications.
  3. It tolerates inhibition better. Because the readout is endpoint presence or absence rather than amplification efficiency, partial inhibition that would shift a cycle threshold has less effect on a count. That matters for difficult matrices where quantitative PCR is unreliable.
  4. The dynamic range is set by the partition count. Too few target molecules and precision is poor; too many and every partition is positive and the count saturates. The usable range follows from how many partitions the instrument makes, so samples must be diluted into it rather than run as they arrive.
  5. Thresholding is a decision, and it should be a rule. Separating positive from negative partitions on a fluorescence amplitude plot is where the result is actually made. Set the rule in advance, include a no-template control on every plate, and record the threshold with the data.

Assay design, which is not the same as for qPCR

Amplicons should be short, and a restriction digest of genomic DNA before partitioning separates tandem copies that would otherwise share a partition and be counted once. Both are routine steps that people carry over from quantitative PCR and omit.

Probe-based chemistry is the norm and multiplexing is possible by amplitude as well as by colour, which lets a single well carry more targets than the detector count suggests.

Throughput and cost per sample

Droplet generation, amplification and reading are separate steps and the whole cycle is slower than a quantitative PCR plate. Consumables are proprietary and considerably more expensive per sample.

For routine quantification of an abundant target, quantitative PCR remains faster and cheaper. Digital methods earn their cost where the counting is what makes the answer possible.

Contamination control, which matters more here

An endpoint count of rare events is exquisitely sensitive to a trace of amplicon in the laboratory. Separate pre and post amplification areas, dedicated pipettes and filter tips, and a no-template control on every plate.

Investigate a positive no-template control rather than repeating around it. On a rare variant assay, a low level contamination produces a plausible result rather than an obviously wrong one.

Common questions

What does a droplet pcr machine do differently from quantitative PCR?
It partitions the reaction into thousands of independent amplifications and counts the positives, giving an absolute concentration by Poisson statistics rather than a value read off a standard curve.
When is a digital pcr instrument worth it?
For rare variant detection against a background, for small copy number differences, for absolute quantification without a reference standard, and for samples where inhibition makes quantitative PCR unreliable.
What limits the dynamic range?
The number of partitions. Below a few target molecules the counting statistics are poor, and above the point where nearly every partition is positive the count saturates. Samples have to be diluted into the usable window.
Is it more accurate than qPCR?
For absolute quantification and small differences, generally yes, because it removes the standard curve and the amplification efficiency assumption. It is also slower, more expensive per sample and has a narrower dynamic range.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/droplet-digital-pcr/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices